Bertrand Louveaux is a Global Elite Thought Leader in the competition space whose world-class practice runs the gamut of related matters from merger control to European Commission and CMA investigations.
Bertrand’s practice spans merger control, competition litigation, market inquiries and competition investigations. He has extensive experience of representing clients before the European Commission and the Competition and Markets Authority. He works in the firm’s London and Brussels offices.
Bertrand’s recent highlights include advising Marsh & McLennan on its acquisition of Jardine Lloyd Thompson; Rolls-Royce on the sale of its marine business to Kongsberg; DS Smith on its acquisition of Europac; GlaxoSmithKline on its divestment of Horlicks and other consumer healthcare nutrition brands to Unilever; and on its buyout of Novartis’ interest in their consumer healthcare JV; Platts on the European Commission’s investigation into the alleged manipulation of published prices for a number of oil and biofuel products; a major international bank on the forex investigations and a party to the CMA’s audit market study.
He is recognised as a leading individual by Chambers and Partners, The Legal 500 and Who’s Who Legal.